22NW, LP - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 40 filers reported holding LIANBIO in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
22NW, LP ownership history of LIANBIO
ValueSharesWeighting
Q4 2023$9,886,201
+200.0%
2,211,6780.0%6.44%
+174.3%
Q3 2023$3,295,400
+923.5%
2,211,678
+1466.1%
2.35%
+1068.2%
Q2 2023$321,988
+16.3%
141,2230.0%0.20%
+18.2%
Q1 2023$276,797
+19.5%
141,2230.0%0.17%
+36.0%
Q4 2022$231,606
-17.9%
141,2230.0%0.12%
-21.4%
Q3 2022$282,000
-7.5%
141,2230.0%0.16%
-1.9%
Q2 2022$305,000141,2230.16%
Other shareholders
LIANBIO shareholders Q2 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,282,084$8,467,0004.92%
Perceptive Advisors 56,319,960$208,947,0004.18%
VR Adviser, LLC 5,378,341$19,954,0003.23%
SCHF (GPE), LLC 937,500$3,478,0001.08%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$12,296,0000.73%
RA Capital Management 7,655,015$28,400,0000.62%
Logos Global Management LP 412,837$1,532,0000.20%
Affinity Asset Advisors, LLC 325,000$1,206,0000.19%
SPHERA FUNDS MANAGEMENT LTD. 275,007$1,020,0000.14%
MYDA Advisors LLC 86,000$319,0000.13%
View complete list of LIANBIO shareholders